LARS anticorps (C-Term)
Aperçu rapide pour LARS anticorps (C-Term) (ABIN2297313)
Antigène
Voir toutes LARS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- LARS, CT (Leucyl-tRNA Synthetase Cytoplasmic, LeuRS, LEUS, LRS, FLJ10595, FLJ21788, hr025Cl, HSPC192, KIAA1352, LARS1, Leucine-tRNA Ligase, PIG44, RNTLS)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- Synthetic peptide selected from the C-terminal region of human LARS (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Autre désignation
- LARS
-
NCBI Accession
- NP_064502
-
UniProt
- Q9P2J5
-
Pathways
- EGFR Signaling Pathway
Antigène
-